Su questa pagina
CBIO Crescent Biopharma, Inc. - Common Stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Lug 30, 2026
$14,32
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$8,72minimo 52 sett.
$27,41massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$397M
P/E
-29.2
EPS
$-0.59
Ricavi
$11M
i tuoi badge
Intervallo 52 sett.
$9–$27
Rating Analisti
BUY
Prezzo Obiettivo
$31
P/E
-29.2
ROE
-90.0%
Margine di Profitto Netto
-1419.6%
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
CBIO Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$14.32
Capitalizzazione di Mercato (MRQ)
$397M
P/E
-29.2
EPS
$-0.59
Ricavi
$11M
ROE
-90.0%
Intervallo 52 sett.
$9–$27
CBIO Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Split azionari
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 16 Giugno 2025 | 1-for-100 | Inverso |
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$11M2016-12-31 → 2025-12-31
EPS$-0.592019-12-31 → 2024-12-31
Flusso di cassa libero$-72M2016-12-31 → 2025-12-31
Margine netto-1419.6%2016-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | CBIO | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E | -29.2media 5 anni ≈-186.2 | ≈-186.2 | · | · | |
| P/S | 36.4media 5 anni ≈436476.1 | ≈436476.1 | 144.0 | Sottovalutato | |
| P/B (MRQ) | 2.4media 5 anni ≈235.3 | ≈235.3 | 3.0 | Valore equo | |
| Prezzo / FCF (TTM) | -5.4media 5 anni ≈-195.4 | ≈-195.4 | · | · | |
| Prezzo / Flusso di cassa (TTM) | -5.5media 5 anni ≈-195.6 | ≈-195.6 | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 1.9media 5 anni ≈218.3 | ≈218.3 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | CBIO | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Operating Margin (Margine Operativo) | -1407.5%media 5 anni ≈-115708.9% | ≈-115708.9% | -2380.1% | In linea | |
| EBITDA Margin (Margine EBITDA) | -1407.5%media 5 anni ≈-115708.9% | ≈-115708.9% | -2380.1% | In linea | |
| Pretax Margin (Margine ante imposte) | -1401.2% | · | -5050.3% | Di prim'ordine | |
| Net Profit Margin (Margine di Profitto Netto) | -1419.6%media 5 anni ≈-109533.6% | ≈-109533.6% | -2240.9% | In linea | |
| ROA | -111.6%media 5 anni ≈-87.8% | ≈-87.8% | -40.8% | Debole | |
| ROE | -90.0%media 5 anni ≈-447.8% | ≈-447.8% | -52.8% | Debole | |
| ROIC | -76.2% | · | -39.0% | Debole |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | CBIO | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 9.7media 5 anni ≈5.7 | ≈5.7 | 12.9 | Bassa liquidità | |
| Quick Ratio | 6.4media 5 anni ≈5.5 | ≈5.5 | 10.5 | In linea |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | CBIO | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | -86.7%media 5 anni ≈-89.6% | ≈-89.6% | · | · | |
| Revenue CAGR 3Y (CAGR Ricavi 3Y) | 424.9% | · | · | · | |
| Revenue CAGR 5Y (CAGR Ricavi 5Y) | 1.3% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | CBIO | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 0.1media 5 anni ≈0.0 | ≈0.0 | 0.0 | Di prim'ordine | |
| Receivables Turnover (Rotazione dei crediti) | 1.2 | · | · | · | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$157.2K | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y
Pagamento annualizzato≈$96.00
| Data ex-dividendo | Importo | Valuta | Rendimento |
|---|---|---|---|
| Gen 13, 2023 | $24,00 | USD | ≈55.3% |
| Set 21, 2022 | $143,00 | USD | ≈223.4% |
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-0.05%
Prossimo report
Nov 04, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | $-0.74 | $-0.81 | 8.7% | |
| 31 Marzo 2026 | $-0.70 | $-0.97 | 27.5% | |
| 31 Dicembre 2025 | $-0.54 | $-2.57 | 79.0% | |
| 30 Settembre 2025 | $-1.27 | $-2.02 | 37.2% | |
| 30 Giugno 2025 | $-4.93 | $-1.80 | -174.2% | |
| 31 Marzo 2025 | $-4.00 | $-5.10 | 21.6% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11M | · | $10.0K | $75.0K | $1M | $10M | · | · | · | $18.5K | $20M | $15M | |
| R&D Expense | $138M | $14M | $20M | $28M | $47M | $45M | $47M | $40M | $24M | $23M | $25M | $20M | |
| SG&A Expense | $25M | $18M | $19M | $19M | $17M | $17M | $14M | $11M | $10M | $9M | $8M | $7M | |
| Operating Expenses | $163M | $40M | $39M | $47M | $65M | $62M | $61M | $52M | $34M | $32M | $33M | $26M | |
| Operating Income | $-153M | $-40M | $-39M | $-47M | $-63M | $-52M | $-61M | $-52M | $-34M | $-32M | $-13M | $-11M | |
| Other Non-op | · | $2M | $2M | · | · | · | · | · | $651.2K | $103.6K | $15.3K | $18.2K | |
| Pretax Income | $-152M | · | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $2M | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-154M | $-38M | $-37M | $-47M | $-63M | $-51M | $-58M | $-48M | $-33M | $-32M | $-13M | $-11M | |
| EPS (Basic) | · | $-0.59 | $-0.58 | $-0.89 | $-1.23 | $-1.12 | $-1.34 | · | · | · | · | $-0.60 | |
| EPS (Diluted) | · | $-0.59 | $-0.58 | $-0.89 | $-1.23 | $-1.12 | $-1.34 | · | · | · | · | $-0.60 | |
| Shares (Basic) | · | 64,477,249 | 63,342,465 | 52,531,173 | 51,453,204 | 45,721,139 | 43,254,782 | · | · | · | · | 18,452,252 | |
| Shares (Diluted) | · | 64,477,249 | 63,342,465 | 52,531,173 | 51,453,204 | 45,721,139 | 43,254,782 | · | · | · | · | 18,452,252 | |
| EBITDA | $-153M | $-40M | $-39M | $-47M | $-63M | $-52M | $-61M | $-52M | $-34M | $-32M | $-13M | $-11M |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $213M | $35M | $42M | $48M | $90M | $137M | $158M | $210M | $124M | $40M | $47M | $55M | |
| Receivables | $18M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $5M | $38.0K | $2M | $3M | $533.8K | $1M | $4M | $2M | $3M | $478.5K | $441.8K | $916.2K | |
| Other Current Assets | $5M | $38.0K | · | · | · | · | · | · | · | · | · | · | |
| Current Assets | $237M | $35M | $44M | $51M | $91M | $138M | $163M | $212M | $127M | $41M | $47M | $56M | |
| PP&E (Net) | $846.0K | $0 | · | $242.4K | $368.8K | $620.7K | $822.9K | $957.2K | $1M | $1M | $521.4K | $452.3K | |
| PP&E (Gross) | · | · | · | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | $1M | |
| Accum. Depreciation | · | · | · | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $902.1K | $905.5K | |
| Other Non-current Assets | $1M | $813.0K | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $240M | $36M | $45M | $52M | $94M | $143M | $168M | $215M | $129M | $42M | $48M | $57M | |
| Accounts Payable | · | $329.3K | $868.1K | $970.2K | $2M | $2M | $1M | $3M | $3M | $2M | $564.2K | $874.0K | |
| Accrued Liabilities | $16M | $2M | $5M | $7M | $9M | $9M | $9M | $6M | $4M | $3M | $6M | $5M | |
| Current Liabilities | $36M | $10M | $7M | $9M | $12M | $12M | $11M | $9M | $8M | $6M | $8M | $6M | |
| Capital Leases | $1M | $0 | $66.8K | · | $918.6K | $2M | $3M | · | · | · | · | · | |
| Total Liabilities | $37M | $47M | $7M | $9M | $13M | $15M | $14M | $9M | $9M | $7M | $8M | $6M | |
| Common Stock | $28.0K | $1.0K | $64.4K | $54.4K | $52.3K | $49.0K | $43.5K | $43.2K | $34.4K | $23.2K | $19.0K | $18.9K | |
| Paid-in Capital | $371M | $2M | $495M | $462M | $454M | $438M | $413M | $406M | $272M | $154M | $128M | $125M | |
| Retained Earnings | $-172M | $-18M | $-456M | $-420M | $-373M | $-309M | $-258M | $-201M | $-152M | $-119M | $-87M | $-74M | |
| Stockholders' Equity | $203M | $-15M | $38M | $43M | $82M | $128M | $154M | $205M | $120M | $35M | $40M | $51M | |
| Liabilities + Equity | $240M | $36M | $45M | $52M | $94M | $143M | $168M | $215M | $129M | $42M | $48M | $57M | |
| Shares Outstanding | 27,556,767 | 1,018,604 | 64,393,744 | 54,377,798 | 52,313,894 | 49,017,622 | 43,466,933 | 43,160,751 | 34,359,799 | 23,250,023 | 19,050,204 | 18,939,838 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $13M | $5M | $4M | $4M | $6M | $7M | $6M | $5M | $4M | $3M | $2M | $2M | |
| Deferred Tax | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Restructuring | · | $7M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-72M | $-31M | $-35M | $-46M | $-57M | $-39M | $-52M | $-43M | $-30M | $-30M | $-8M | $-4M | |
| CapEx | $919.0K | $10.0K | $21.4K | $84.2K | $14.9K | $68.5K | $144.9K | $125.6K | $294.1K | $704.2K | $268.6K | $212.6K | |
| Investing Cash Flow | $-73M | $20.0K | $-21.4K | $-84.2K | $-14.9K | $-68.5K | $-144.9K | $-125.6K | $-294.1K | $-704.2K | $-268.6K | · | |
| Stock Issued | $0 | · | $29M | $4M | $11M | $18M | · | $128M | $114M | $24M | · | $57M | |
| Net Stock Activity | $0 | · | $29M | $4M | $11M | $18M | · | $128M | $114M | $24M | · | $57M | |
| Financing Cash Flow | $323M | $5.4K | $29M | $4M | $11M | $18M | $412.9K | $129M | $114M | $24M | $114.1K | · | |
| Net Change in Cash | $179M | $-31M | $-6M | $-42M | $-47M | $-21M | $-52M | $86M | $84M | $-7M | $-8M | $53M | |
| Free Cash Flow | $-72M | $-31M | $-35M | $-47M | $-58M | $-39M | $-52M | $-43M | $-30M | $-30M | $-9M | $-4M |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1407.5% | · | -392752.9% | -63204.4% | -5470.7% | -506.8% | · | · | · | -172505.3% | -63.7% | -74.1% | |
| Net Margin | -1419.6% | · | -368994.2% | -62251.7% | -5469.0% | -502.1% | · | · | · | -171945.1% | -63.6% | -74.0% | |
| Pretax Margin | -1401.2% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1407.5% | · | -392752.9% | -63204.4% | -5470.7% | -506.8% | · | · | · | -172505.3% | -63.7% | -74.1% | |
| ROA | -111.6% | -134.3% | -76.0% | -63.9% | -53.5% | -32.8% | -30.2% | -28.1% | -38.9% | -70.0% | -24.2% | -35.6% | |
| ROE | -90.0% | -1888.5% | -86.9% | -102.6% | -71.2% | -38.3% | -36.0% | -22.8% | -42.9% | -84.0% | -28.0% | -41.4% | |
| ROIC | -76.2% | · | · | · | · | · | · | · | · | · | · | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.6 | 1.9 | 6.4 | 5.7 | 7.7 | 11.1 | 14.8 | 24.2 | 15.6 | 6.4 | 6.1 | 8.7 | |
| Quick Ratio | 6.4 | 1.9 | 6.1 | 5.4 | 7.6 | 11.0 | 14.4 | 24.0 | 15.2 | 6.3 | 6.0 | 8.5 |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.0 | 0.0 | 0.0 | 0.1 | · | · | · | 0.0 | 0.4 | 0.5 | |
| Receivables Turnover | 1.2 | · | · | · | · | · | · | · | · | · | · | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.37 | $0.08 | $0.60 | $0.79 | $1.56 | $2.62 | $3.55 | $4.76 | $3.48 | $1.52 | $2.12 | $2.68 | |
| Revenue / Share | · | · | $0.00 | $0.00 | $0.02 | · | · | · | · | · | · | $0.81 | |
| Cash Flow / Share | · | $-0.48 | $-0.55 | $-0.88 | $-1.12 | · | · | · | · | · | · | $-0.23 | |
| Cash / Share | $7.74 | $0.17 | $0.65 | $0.88 | $1.73 | $2.80 | $3.64 | $4.86 | $3.61 | $1.72 | $2.46 | $2.91 | |
| EPS (TTM) | $-0.49 | $-0.59 | $-0.58 | $-0.89 | $-1.23 | $-1.12 | $-1.34 | $-0.75 | $-0.75 | $-0.75 | $-0.71 | $-0.60 |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | -86.7% | -93.5% | -88.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 424.9% | · | -90.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 1.3% | · | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $11M | · | $10.0K | $75.0K | $1M | $10M | · | · | · | $18.5K | $20M | $15M | |
| Net Income TTM | $-154M | $-38M | $-37M | $-47M | $-63M | $-51M | $-58M | $-48M | $-33M | $-32M | $-13M | $-11M | |
| Market Cap | $327M | $1.61B | $15.20B | $16.48B | $7.53B | $18.43B | $22.99B | $40.87B | $57.69B | $14.18B | $10.90B | $13.64B | |
| P/E | -24.2 | -42.4 | -406.9 | -340.4 | -117.1 | -335.7 | -394.8 | -1262.7 | -2238.7 | -813.3 | -805.6 | -1200.0 | |
| P/S | 30.1 | · | 1519692.4 | 219686.3 | 6495.4 | 1813.5 | · | · | · | 766622.4 | 542.9 | 907.5 | |
| P/B | 1.6 | 303.4 | 395.6 | 383.8 | 92.3 | 143.7 | 149.1 | 198.9 | 481.9 | 401.8 | 269.2 | 268.4 | |
| P / Tangible Book | 1.6 | · | 395.6 | 383.8 | 92.3 | 143.7 | · | · | · | · | · | · | |
| P / Cash Flow | -4.6 | -51.8 | -435.7 | -354.7 | -131.0 | -469.7 | -442.3 | -943.3 | -1938.0 | -477.0 | -1322.1 | -3185.0 | |
| P / FCF | -4.5 | -51.8 | -435.4 | -354.0 | -131.0 | -468.8 | -441.1 | -940.5 | -1919.0 | -466.0 | -1280.4 | -3034.3 | |
| Earnings Yield | -4.1% | -2.4% | -0.25% | -0.29% | -0.85% | -0.30% | -0.25% | -0.08% | -0.04% | -0.12% | -0.12% | -0.08% |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $1M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | $0 | · | |
| R&D Expense | $19M | $18M | $106M | $20M | $12M | $11M | $233.2K | $2M | $6M | $6M | $5M | $5M | $4M | $5M | $6M | $5M | |
| SG&A Expense | $9M | $8M | $9M | $6M | $9M | $4M | $5M | $4M | $4M | $5M | $4M | $5M | $5M | $6M | $5M | $4M | |
| Operating Expenses | $28M | $26M | $114M | $26M | $21M | $14M | $7M | $11M | $10M | $11M | $10M | $10M | $9M | $11M | $11M | $9M | |
| Operating Income | $-26M | $-25M | $-103M | $-26M | $-21M | $-14M | $-7M | $-11M | $-10M | $-11M | $-10M | $-10M | $-9M | $-11M | $-11M | $-9M | |
| Other Non-op | $2M | $1M | · | $1M | $-760.0K | $-924.0K | $110.1K | $1M | · | · | $512.2K | $611.0K | · | · | · | · | |
| Income Tax | $0 | $0 | $2M | $0 | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-25M | $-23M | $-23M | $-25M | $-22M | $-15M | $-7M | $-10M | $-10M | $-11M | $-9M | $-9M | $-8M | $-10M | $-10M | $-9M | |
| EPS (Basic) | · | · | · | · | · | $-0.04 | $-0.11 | $-0.15 | $-0.16 | $-0.17 | $-0.14 | $-0.14 | $-0.13 | $-0.17 | $-0.20 | $-0.16 | |
| EPS (Diluted) | · | · | · | · | · | · | $-0.24 | $-0.15 | $-0.16 | $-0.04 | $-0.14 | $-0.14 | $-0.13 | $-0.17 | $-0.20 | $-0.16 | |
| Shares (Basic) | · | · | · | · | · | 64,522,257 | · | 64,483,958 | 64,483,848 | 64,457,233 | · | 64,349,709 | 64,276,184 | 60,350,127 | · | 52,423,944 | |
| Shares (Diluted) | · | · | · | · | · | · | · | 64,483,958 | 64,483,848 | 64,522,257 | · | 64,349,709 | 64,276,184 | 64,457,233 | · | 52,423,944 | |
| EBITDA | $-26M | · | · | $-26M | $-21M | · | · | $-11M | $-10M | $-11M | · | $-10M | $-9M | $-11M | · | $-9M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $172M | $189M | $213M | $133M | $153M | $6M | $11M | $14M | $22M | $31M | $42M | $49M | $58M | $65M | $48M | $52M | |
| Receivables | $0 | $0 | $18M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $7M | $6M | $5M | $1M | $2M | $378.0K | $371.3K | $1M | $1M | $2M | $2M | $3M | $2M | $3M | $3M | $2M | |
| Other Current Assets | $7M | $6M | $5M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Current Assets | $179M | $196M | $237M | $135M | $154M | $6M | $11M | $16M | $24M | $33M | $44M | $52M | $60M | $68M | $51M | $54M | |
| PP&E (Net) | $876.0K | $929.0K | $846.0K | $782.0K | $193.0K | · | · | · | · | · | · | $133.0K | $167.9K | $200.7K | · | $288.1K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | $3M | $3M | $3M | · | $3M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | $3M | $2M | $2M | · | $2M | |
| Other Non-current Assets | $1M | $1M | $1M | $1M | $1M | · | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $183M | $199M | $240M | $138M | $157M | $6M | $11M | $16M | $24M | $34M | $45M | $53M | $62M | $69M | $52M | $56M | |
| Accounts Payable | · | · | · | · | · | $104.7K | $329.3K | $581.8K | $950.8K | $755.5K | $868.1K | $329.9K | $241.5K | $480.2K | $970.2K | $852.1K | |
| Accrued Liabilities | $7M | $4M | $16M | $9M | $8M | $3M | $5M | $3M | $3M | $4M | $5M | $5M | $6M | $6M | $7M | $6M | |
| Current Liabilities | $19M | $14M | $36M | $20M | $17M | $3M | $6M | $4M | $4M | $5M | $7M | $6M | $7M | $7M | $9M | $8M | |
| Capital Leases | $966.0K | $1M | $1M | $1M | $1M | · | · | · | · | · | $66.8K | $262.1K | $448.8K | · | · | $95.6K | |
| Total Liabilities | $20M | $15M | $37M | $22M | $18M | $3M | $6M | $4M | $4M | $5M | $7M | $7M | $7M | $7M | $9M | $8M | |
| Common Stock | $28.0K | $28.0K | $28.0K | $14.0K | $14.0K | $64.5K | $64.5K | $64.5K | $64.5K | $64.5K | $64.4K | $64.4K | $64.3K | $64.2K | $54.4K | $52.4K | |
| Paid-in Capital | $379M | $375M | $371M | $192M | $190M | $500M | $500M | $498M | $497M | $496M | $495M | $494M | $493M | $492M | $462M | $457M | |
| Retained Earnings | $-220M | $-195M | $-172M | $-79M | $-55M | $-497M | $-494M | $-487M | $-477M | $-467M | $-456M | $-447M | $-438M | $-430M | $-420M | $-409M | |
| Stockholders' Equity | $163M | $184M | $203M | $117M | $139M | $3M | $5M | $11M | $20M | $29M | $38M | $47M | $55M | $62M | $43M | $48M | |
| Liabilities + Equity | $183M | $199M | $240M | $138M | $157M | $6M | $11M | $16M | $24M | $34M | $45M | $53M | $62M | $69M | $52M | $56M | |
| Shares Outstanding | 27,756,044 | 27,571,935 | 27,556,767 | 13,892,516 | 13,892,562 | 64,532,091 | 64,483,958 | 64,483,958 | 64,483,958 | 64,450,835 | 64,393,744 | 64,368,843 | 64,313,333 | 64,245,224 | 54,377,798 | 52,423,944 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $4M | $5M | $2M | $6M | $1M | $1M | $1M | $1M | $1M | $908.4K | $887.8K | $858.1K | $870.2K | $899.2K | $914.0K | |
| Restructuring | · | · | · | · | · | · | · | $5M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-19M | $-9M | $-27M | $-18M | $-22M | $-11M | $-4M | $-8M | $-9M | $-11M | $-8M | $-9M | $-7M | $-12M | $-8M | $-9M | |
| CapEx | $13.0K | $147.0K | $193.0K | $586.0K | $140.0K | $0 | $0 | $0 | $2.5K | $7.4K | $801 | $7.9K | $10.5K | $2.2K | $1 | $2.5K | |
| Investing Cash Flow | $2M | $-8M | $-72M | $-586.0K | $-140.0K | $0 | $30.0K | $0 | $-2.5K | $-7.4K | $-801 | $-7.9K | $-10.5K | $-2.2K | $-1 | $-2.5K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $29M | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $29M | · | · | |
| Financing Cash Flow | $136.0K | $-7M | $179M | $-1M | $147M | $-1M | $0 | $0 | $500 | $4.9K | $999 | $61.6K | $20.1K | $29M | · | · | |
| Net Change in Cash | $-18M | $-24M | $80M | $-19M | $123M | $-12M | $-4M | $-8M | $-9M | $-11M | $-8M | $-9M | $-7M | $17M | $-4M | $-9M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-11M | · | · | · | $-12M | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -14.6% | · | · | -32.0% | -24.0% | · | · | · | -23.4% | -20.8% | · | -16.9% | -13.0% | -13.8% | · | -10.4% | |
| ROE | -16.4% | · | · | -38.4% | -27.4% | · | · | · | -27.0% | -23.6% | · | -19.4% | -14.9% | -15.9% | · | -11.8% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.7 | · | · | 6.6 | 9.2 | · | · | · | 5.5 | 6.3 | · | 8.1 | 9.2 | 10.1 | · | 6.9 | |
| Quick Ratio | 9.3 | · | · | 6.6 | 9.1 | · | · | · | 5.1 | 5.9 | · | 7.7 | 8.8 | 9.6 | · | 6.7 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.88 | · | · | $8.40 | $10.02 | · | · | · | $0.31 | $0.45 | · | $0.72 | $0.85 | $0.97 | · | $0.92 | |
| Cash Flow / Share | · | · | · | · | · | · | · | · | · | $-0.16 | · | · | · | $-0.19 | · | · | |
| Cash / Share | $6.18 | · | · | $9.59 | $10.99 | · | · | · | $0.35 | $0.49 | · | $0.77 | $0.90 | $1.01 | · | $0.98 | |
| EPS (TTM) | $-0.59 | $-0.49 | · | $-0.59 | $-0.59 | $-0.59 | · | $-0.49 | $-0.48 | $-0.45 | · | $-0.64 | $-0.66 | $-0.78 | · | $-1.02 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-96M | $-93M | · | $-69M | $-54M | $-42M | · | $-40M | $-39M | $-37M | · | $-38M | $-37M | $-42M | · | $-54M | |
| Market Cap | $500M | · | · | $165M | $224M | · | · | · | $1.81B | $19.34B | · | $9.66B | $11.19B | $8.09B | · | $2.88B | |
| P/E | -30.5 | -37.5 | · | -20.2 | -27.4 | -35.6 | · | -34.7 | -58.3 | -666.7 | · | -234.4 | -263.6 | -161.5 | · | -53.9 | |
| P/B | 3.1 | · | · | 1.4 | 1.6 | · | · | · | 90.0 | 668.8 | · | 207.4 | 204.2 | 130.2 | · | 59.9 | |
| P / Tangible Book | 3.1 | 2.8 | · | 1.4 | 1.6 | 401.5 | · | 96.4 | 90.0 | 668.8 | · | 207.4 | 204.2 | 130.2 | · | 59.9 | |
| P / Cash Flow | · | · | · | · | · | · | · | · | · | -1839.9 | · | · | · | -697.4 | · | · | |
| Earnings Yield | -3.3% | -2.7% | · | -5.0% | -3.7% | -2.8% | · | -2.9% | -1.7% | -0.15% | · | -0.43% | -0.38% | -0.62% | · | -1.8% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $11M | · | $10.0K | $75.0K | $1M |
| Margine Operativo % | -1407.5% | · | -392752.9% | -63204.4% | -5470.7% |
| Utile netto | $-154M | $-38M | $-37M | $-47M | $-63M |
| EPS Diluito | · | $-0.59 | $-0.58 | $-0.89 | $-1.23 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rapporto corrente | 6.6 | 1.9 | 6.4 | 5.7 | 7.7 |
| Quick Ratio | 6.4 | 1.9 | 6.1 | 5.4 | 7.6 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-72M | $-31M | $-35M | $-47M | $-58M |
Proprietari istituzionali (13F) 82 filer · $526.1M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
82
Valore detenuto
$526.1M
Nuove posizioni
32
Posizioni chiuse
12
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 32 (+15 vs trimestre precedente) | 12 (+2 vs trimestre precedente) | 17 (0 vs trimestre precedente) | 14 (+6 vs trimestre precedente) | +4.0M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| FMR LLC | $74.403.252 | 4.133.514 | 14,14% | Azioni |
| BVF INC/IL | $49.477.734 | 2.748.763 | 9,40% | Azioni |
| Fairmount Funds Management LLC | $49.461.588 | 2.747.866 | 9,40% | Azioni |
| Venrock Adviser, LLC | $38.404.368 | 2.133.576 | 7,30% | Azioni |
| Logos Global Management LP | $34.200.000 | 1.900.000 | 6,50% | Azioni |
| FCPM III SERVICES B.V. | $30.201.336 | 1.677.852 | 5,74% | Azioni |
| Balyasny Asset Management L.P. | $29.932.506 | 1.662.917 | 5,69% | Azioni |
| Vestal Point Capital, LP | $29.340.000 | 1.630.000 | 5,58% | Azioni |
| Opaleye Management Inc. | $23.748.318 | 1.319.351 | 4,51% | Azioni |
| BlackRock, Inc. | $22.891.716 | 1.271.762 | 4,35% | Azioni |
| TANG CAPITAL MANAGEMENT LLC | $20.880.000 | 1.160.000 | 3,97% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $13.819.590 | 767.755 | 2,63% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $7.269.462 | 403.859 | 1,38% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $6.923.843 | 384.576 | 1,32% | Azioni |
| JENNISON ASSOCIATES LLC | $6.813.126 | 378.507 | 1,30% | Azioni |
| RTW INVESTMENTS, LP | $6.711.408 | 372.856 | 1,28% | Azioni |
| NEXTBio Capital Management LP | $6.711.408 | 372.856 | 1,28% | Azioni |
| VANGUARD GROUP INC | $6.612.021 | 557.506 | 1,26% | Azioni |
| Remedium Capital Partners, LLC | $6.502.500 | 361.250 | 1,24% | Azioni |
| STATE STREET CORP | $5.680.566 | 315.587 | 1,08% | Azioni |
| AMERIPRISE FINANCIAL INC | $5.446.224 | 302.568 | 1,04% | Azioni |
| Point72 Asset Management, L.P. | $5.400.000 | 300.000 | 1,03% | Azioni |
| MARSHALL WACE, LLP | $3.857.400 | 214.300 | 0,73% | Azioni |
| PERCEPTIVE ADVISORS LLC | $3.724.956 | 206.942 | 0,71% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3.398.454 | 188.803 | 0,65% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $3.363.732 | 186.874 | 0,64% | Azioni |
| STEMPOINT CAPITAL LP | $3.282.876 | 182.382 | 0,62% | Azioni |
| UBS Group AG | $3.153.276 | 175.182 | 0,60% | Azioni |
| NORTHERN TRUST CORP | $2.498.004 | 138.778 | 0,47% | Azioni |
| Exome Asset Management LLC | $2.299.842 | 127.769 | 0,44% | Azioni |
| SECTORAL ASSET MANAGEMENT INC | $2.183.400 | 121.300 | 0,42% | Azioni |
| Woodline Partners LP | $1.700.784 | 94.488 | 0,32% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $1.354.050 | 75.225 | 0,26% | Azioni |
| Burkehill Global Management, LP | $1.332.000 | 74.000 | 0,25% | Azioni |
| Blackstone Inc. | $1.127.646 | 62.647 | 0,21% | Azioni |
| SILVERARC CAPITAL MANAGEMENT, LLC | $1.063.872 | 59.104 | 0,20% | Azioni |
| Y-Intercept (Hong Kong) Ltd | $914.832 | 50.824 | 0,17% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $904.644 | 50.258 | 0,17% | Azioni |
| Nuveen, LLC | $857.322 | 47.629 | 0,16% | Azioni |
| Bank of New York Mellon Corp | $824.004 | 45.778 | 0,16% | Azioni |
| Stonepine Capital Management, LLC | $720.000 | 40.000 | 0,14% | Azioni |
| BANK OF AMERICA CORP /DE/ | $464.778 | 25.821 | 0,09% | Azioni |
| RHUMBLINE ADVISERS | $458.766 | 25.487 | 0,09% | Azioni |
| MOORE CAPITAL MANAGEMENT, LP | $450.000 | 25.000 | 0,09% | Azioni |
| Squarepoint Ops LLC | $434.988 | 24.166 | 0,08% | Azioni |
| AMERICAN CENTURY COMPANIES INC | $410.490 | 22.805 | 0,08% | Azioni |
| TWO SIGMA ADVISERS, LP | $385.450 | 32.500 | 0,07% | Azioni |
| WELLS FARGO & COMPANY/MN | $354.600 | 19.700 | 0,07% | Azioni |
| ADAR1 Capital Management, LLC | $328.950 | 18.275 | 0,06% | Azioni |
| Virtus Investment Advisers, LLC | $328.644 | 18.258 | 0,06% | Azioni |
Attivisti e proprietari del 5%+ 4 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P., Peter Harwin, Tomas Kiselak ×3 depositi | 20 Luglio 2026 | 16,52% | Modifica | Investimento passivo | SEC |
| Adage Capital Management, L.P., Robert Atchinson, Phillip Gross ×2 depositi | 20 Giugno 2025 | 0,37% | Modifica | · | SEC |
| 08 Maggio 2024 | · | Deposito iniziale | · | SEC | |
| New Enterprise Associates 10, Limited Partnership, NEA Partners 10, Limited Partnership, New Enterprise Associates 13, L.P., NEA Partners 13, L.P., NEA 13 GP, LTD, Anthony A. Florence, Jr, Mohamad H. Makhzoumi, Scott D. Sandell ×4 depositi | 29 Febbraio 2024 | · | Deposito iniziale | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 34 insider · 16 dirigenti · 18 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Joshua T Brumm | Chief Executive Officer | 18 Settembre 2026 S | 271.765 | 0 | 3 | $-920.842 |
| Harout Semerjian | Chief Executive Officer | 12 Gennaio 2024 A | 25.000 | 0 | 0 | $0 |
| Richard William Scalzo | Chief Financial Officer | 16 Settembre 2026 S | 19.730 | 0 | 2 | $-30.172 |
| Brian M. Hahn | SVP Finance, CFO | 18 Giugno 2024 P | 70.643 | 0 | 0 | $0 |
| Jonathan Mcneill | President and COO | 18 Settembre 2026 S | 134.588 | 0 | 3 | $-446.912 |
| Jan Pinkas | Chief Scientific Officer | 16 Settembre 2026 S | 21.581 | 0 | 2 | $-34.949 |
| Barbara Harlin Bispham | General Counsel and Corporate Secretary. | 16 Settembre 2026 S | 18.710 | 0 | 2 | $-33.010 |
| Ellie Eunkyung Im | Chief Medical Officer | 16 Settembre 2026 S | 21.446 | 0 | 2 | $-33.082 |
| Ryan Lynch | Treasurer, Senior Vice President of Finance and Chief Accounting Officer. | 16 Settembre 2026 S | 13.631 | 0 | 2 | $-12.661 |
| Christopher Grant Doughty | Chief Business Officer | 15 Dicembre 2025 A | 62.194 | 0 | 0 | $0 |
| Edwin Rock | Chief Medical Officer | 21 Giugno 2024 P | 680.403 | 0 | 0 | $0 |
| Bruce S Johnson | SVP & Chief Commercial Officer | 12 Gennaio 2024 A | 138.980 | 0 | 0 | $0 |
| Chinmaya Rath | SVP and Chief Business Officer | 12 Gennaio 2024 A | · | 0 | 0 | $0 |
| Armand Girard | SVP, Chief Business Officer | 11 Novembre 2022 P | 29.161 | 0 | 0 | $0 |
| John L. Magnani | SVP of Research, CSO | 11 Novembre 2022 P | 366.078 | 0 | 0 | $0 |
| Helen M. Thackray | SVP Clinical Development, CMO | 20 Gennaio 2021 A | 183.115 | 0 | 0 | $0 |
| Alexandra Balcom | Direttore | 02 Giugno 2026 A | · | 0 | 0 | $0 |
| Susan Moran | Direttore | 02 Giugno 2026 A | · | 0 | 0 | $0 |
| Jonathan Violin | Direttore | 02 Giugno 2026 A | · | 0 | 0 | $0 |
| David Charles Lubner | Direttore | 02 Giugno 2026 A | · | 0 | 0 | $0 |
| Rachel K. King | Direttore | 01 Maggio 2024 A | 515.194 | 0 | 0 | $0 |
| Scott Koenig | Direttore | 01 Maggio 2024 A | 36.750 | 0 | 0 | $0 |
| Scott Thomas Jackson | Direttore | 01 Maggio 2024 A | 5.250 | 0 | 0 | $0 |
| Mark Alan Goldberg | Direttore | 01 Maggio 2024 A | 24.828 | 0 | 0 | $0 |
| Timothy R Pearson | Direttore | 01 Maggio 2024 A | 24.650 | 0 | 0 | $0 |
| Patricia S Andrews | Direttore | 01 Maggio 2024 A | 58.608 | 0 | 0 | $0 |
| JUNIUS DANIEL M | Direttore | 01 Maggio 2024 A | 98.459 | 0 | 0 | $0 |
| James M Barrett | Direttore | 18 Maggio 2018 A | 4.995.664 | 0 | 0 | $0 |
| John J. Baldwin | Direttore | 29 Giugno 2016 M | 1.210 | 0 | 0 | $0 |
| Franklin H Top JR | Direttore | 17 Maggio 2016 A | 12.294 | 0 | 0 | $0 |
| Michael A Henos | Direttore | 15 Luglio 2015 A | 469.454 | 0 | 0 | $0 |
| William M. Gust | Direttore | 15 Gennaio 2014 C | 409.947 | 0 | 0 | $0 |
| Scott D. Sandell | Proprietario del 10% | 26 Gennaio 2023 S | 2.237.196 | 0 | 0 | $0 |
| Peter J Barris | Proprietario del 10% | 10 Maggio 2018 X | 4.995.664 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 10 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| IWC · iShares Trust | 0,10% | 72.879 SH | 11 Settembre 2026 | Giornaliero |
| IWO · iShares Trust | 0,03% | 202.796 SH | 11 Settembre 2026 | Giornaliero |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,02% | 23.282 SH | 19 Agosto 2026 | Giornaliero |
| IWM · iShares Trust | 0,01% | 544.047 SH | 11 Settembre 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 124.281 SH | 19 Agosto 2026 | Giornaliero |
| RSSL · Global X Funds | 0,01% | 10.277 NS | 31 Luglio 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 83.801 SH | 19 Agosto 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 661.946 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.832 SH | 19 Agosto 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,00% | 39.408 SH | 19 Agosto 2026 | Giornaliero |
CBIO Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 15 analisti
COMPRA
Target mediano
$28.00
+95,5%
6 40,0%
Acquisto forte
7 46,7%
Compra
2 13,3%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
5 analisti · 2026-09-30Target medio $30.60 +113,7%
← Sotto tutti i target
Prezzo attuale $14.32
Basso$27.00
Media$30.60
Alto$35.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| CBIO | $327M | -24.2 | -86.7% | -1419.6% | -90.0% | · |
| ALT | $400M | -3.6 | 105.0% | -214861.0% | -45.6% | · |
| ALLO | $314M | -1.6 | -76.8% | · | -59.9% | · |
| MPLT | $773M | -0.9 | · | · | -151.1% | · |
| MNPR | · | · | · | · | · | · |
| NGNE | $319M | -4.9 | · | · | -33.6% | · |
| ZURA | · | · | · | · | · | · |
| CAPR | $1.66B | -12.8 | -11.6% | · | -51.1% | · |
| PROK | · | · | 1075.0% | -7725.2% | 6.9% | · |
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | · |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | · |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Lug 30, 2026